Work experience: 9 years
Education:
- 2008-2014: Bogomolets National Medical University, specialty "General Medicine";
- 2015-2017: Shupyk National University of Health of Ukraine, specialization in Oncology;
- 2019: Shupyk National University of Health of Ukraine, specialization in Oncosurgery
Membership in associations, societies; attending conferences, thematic improvement courses:
- ESMO Sarcoma & GIST Symposium (Milan, Italy, 2018, 2020) on the treatment of sarcomas and gastrointestinal stromal tumors;
- European Musculo-Skeletal Oncology Society 31st annual meeting (Amsterdam, the Netherlands, 2018), European Musculo-Skeletal Oncology Society 32nd annual meeting (Florence, Italy, 2019) annual meetings of oncologists on the treatment of bone and soft tissue tumors;
- Bone and Soft Tissue Tumors Madrid Course (Madrid, Spain, 2019) - a course on the treatment of bone and soft tissue tumors.
Scientific activity:
- Perspective of Denosumab in the treatment of patients with pulmonary metastases of benign NSCLC on the example of two clinical cases EMSOS abstract book 2018 P. 224- 225, May 9-11, Amsterdam, 2018;
- Modern approaches to antiresorptive therapy in metastatic bone lesions (literature review). Clinical Oncology. 2018. №3(31). С.162-164;
- Results of surgical treatment of patients with sacral tumors using 3D modeling. Clinical Oncology. 2018. №4(32);
- Result of denosumab application in preoperative regimen in treatment of giant cell tumor 30th Annual Meeting of the European Musculo-Skeletal Oncology Society Prog 26-28 April 2017, Budapest, Hungary;
- Comprehensive treatment of patients with metachronous metastases of osteosarcoma: optimization of the treatment algorithm. Clinical Oncology. 2017. №1(25). С.26-28;
- Surgical treatment of patients with metachronous metastases of osteosarcoma in the lungs. Factors of prognosis Clinical surgery №4. 2017. С.24-26.
Priority areas in clinical practice:
- complex treatment and organ-preserving surgery in patients with bone and soft tissue sarcomas;
- surgical treatment of malignant neoplasms of the skin.